Hugh D. C. Smyth - Concepedia

Author

Hugh D. C. Smyth

Also Known As

Beck, Vance P., Diane Burgess, Götte, Matthias, H. D. C. Smyth, H. D. Smyth, H. Smyth, H.D.C. Smyth, Hugh D C Smyth, Hugh D Smyth, Hugh D. C Smyth

263

Publications

7.4K

Citations

H-Index

156

Concepts

All Affiliations

The University of Texas at Austin Austin College University of New Mexico University of North Carolina at Chapel Hill Mansoura University

About

Hugh D. C. Smyth is an author at The University of Texas at Austin specializing in medicine, engineering, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	48	2.1K
2	Engineering	24	39	2.3K
3	Allergy	8	8	307
4	Health Sciences	6	6	215
5	Natural Sciences	4	4	306

Hugh D. C. Smyth

105

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Discrimination of Chiral Compounds Using NMR Spectroscopy Hugh D. C. Smyth, Martín J. Donovan Drug Development and Industrial Pharmacy EngineeringMagnetic Resonance SpectroscopyNatural SciencesSpectroscopyMagnetic Resonance	2008	226
Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms Leisha M. Armijo, Stephen J. Wawrzyniec, Michael Kopciuch, Journal of Nanobiotechnology	2020	166
Physical Characterization of Component Particles Included in Dry Powder Inhalers. I. Strategy Review and Static Characteristics Anthony J. Hickey, Heidi M. Mansour, M Telko, Journal of Pharmaceutical Sciences AsthmaMaterials ScienceEngineeringLung DepositionComponent Particles Included	2007	157
Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes Javier Morales, Kristin Fathe, Ashlee D. Brunaugh, The AAPS Journal Translational MedicineFuture ProspectsOral MucosalImmunologyDrug Delivery Systems	2017	147
Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments Hairui Zhang, J. Sánchez Leal, Melissa Soto, Pharmaceutics NanoparticlesLead FormulationsLnp FormulationsNanotherapeuticsEngineering	2020	146
Controlled Release Pulmonary Administration of Curcumin Using Swellable Biocompatible Microparticles Ibrahim M. El‐Sherbiny, Hugh D. C. Smyth Molecular Pharmaceutics HydrogelsNanomedicineSpray DryingEngineeringPolymer-drug Conjugate	2011	142
Dry Powder Inhaler Device Influence on Carrier Particle Performance Martín J. Donovan, Sin Hyen Kim, Venkat Raman, Journal of Pharmaceutical Sciences AsthmaParticle TechnologyLung DepositionCarrier Particle Performance	2011	118
Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations Martín J. Donovan, Hugh D. C. Smyth International Journal of Pharmaceutics Surface RoughnessMicroemulsionRheologyFood EngineeringPowder Compaction	2010	116
Physical Characterization of Component Particles Included in Dry Powder Inhalers. II. Dynamic Characteristics Anthony J. Hickey, Heidi M. Mansour, M Telko, Journal of Pharmaceutical Sciences Materials ScienceEngineeringLung DepositionComponent Particles IncludedMechanical Engineering	2007	112
Formulation and device design to increase nose to brain drug delivery Zachary N. Warnken, Hugh D. C. Smyth, Alan B. Watts, Journal of Drug Delivery Science and Technology Tissue EngineeringNanomedicineEngineeringMedicineTopical Drug	2016	109

Page 1